The histopathology of transgenes and knockouts in the mammary gland

[1]  R. Cardiff,et al.  Differential expression of the neu transgene in murine mammary tissues. , 1997, International journal of oncology.

[2]  R. Cardiff,et al.  Microcirculation and metastasis in a new mouse mammary tumor model system. , 1997, International journal of oncology.

[3]  L. Hennighausen,et al.  Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J C Reed,et al.  Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. , 1996, Development.

[5]  R. Cardiff,et al.  Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene. , 1996, The American journal of pathology.

[6]  R. Cardiff,et al.  Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice , 1996, Molecular and cellular biology.

[7]  A. Berchuck,et al.  BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[8]  L. Hennighausen,et al.  Understanding mammary gland development through the imbalanced expression of growth regulators , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[9]  P. Leder,et al.  NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. , 1996, Oncogene.

[10]  R. Cardiff,et al.  Activated neu Induces Rapid Tumor Progression (*) , 1996, The Journal of Biological Chemistry.

[11]  G. Stamp,et al.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. , 1995, Genes & development.

[12]  R. Cardiff,et al.  C-myc protein distribution - mammary adenocarcinomas of mtv/myc transgenic mice. , 1995, International journal of oncology.

[13]  R. Cardiff,et al.  Comparative pathology of mammary tumorigenesis in transgenic mice. , 1995, Cancer letters.

[14]  K. Paigen,et al.  A miracle enough: the power of mice , 1995, Nature Medicine.

[15]  W. Muller,et al.  Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. , 1994, Molecular and Cellular Biology.

[16]  G. Cunha.  Role of mesenchymal‐epithelial interactions in normal and abnormal development of the mammary gland and prostate , 1994, Cancer.

[17]  B. Li,et al.  Preferential overexpression of a 172Arg-->Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[18]  Emma Lees,et al.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.

[19]  L. Hennighausen,et al.  Whey acidic protein extrinsically expressed from the mouse mammary tumor virus long terminal repeat results in hyperplasia of the coagulation gland epithelium and impaired mammary development. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[20]  Z. Werb,et al.  Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752] , 1994, The Journal of cell biology.

[21]  R. Coffey,et al.  Cause of Failure of Lactation in Mouse Mammary Tumor Virus/Human Transforming Growth Factor α Transgenic Mice , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[22]  W. Muller,et al.  Mammary tumorigenesis and metastasis in transgenic mice. , 1994, Seminars in cancer biology.

[23]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[24]  W. Muller,et al.  Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity , 1994, Molecular and cellular biology.

[25]  B. Hogan,et al.  Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. , 1993, Genes & development.

[26]  W. Muller,et al.  PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. , 1993, Oncogene.

[27]  R. Cardiff,et al.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Mangues,et al.  Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice. , 1992, Oncogene.

[29]  W. McGuire,et al.  Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. , 1992, Human pathology.

[30]  R. Guzman,et al.  Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice. , 1992, Cancer research.

[31]  R. Cardiff,et al.  Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants. , 1992, Journal of the National Cancer Institute.

[32]  S. Robinson,et al.  Regulation of mammary growth and function by TGF‐β , 1992, Molecular reproduction and development.

[33]  B. Groner.  Oncogene expression in mammary epithelial cells , 1992, Journal of cellular biochemistry.

[34]  B. Hogan,et al.  Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations. , 1992, The American journal of pathology.

[35]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[36]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.

[37]  D. Gallahan,et al.  Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. , 1992, Genes & development.

[38]  D M Barnes,et al.  Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? , 1992, European journal of cancer.

[39]  H. Varmus,et al.  Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice , 1992, Molecular and cellular biology.

[40]  G. Merlino,et al.  Molecular insights into breast cancer from transgenic mouse models , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.

[41]  R. Cardiff,et al.  Transgenic oncogene mice. Tumor phenotype predicts genotype. , 1991, The American journal of pathology.

[42]  J. Bártková,et al.  Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ. , 1990, Human pathology.

[43]  D. Weiner,et al.  Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[44]  B. Hogan,et al.  Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice , 1990, Cell.

[45]  R. Cardiff,et al.  Insertion mutation of the int-1 and int-2 loci by mouse mammary tumor virus in premalignant and malignant neoplasms from the GR mouse strain , 1990, Journal of Virology.

[46]  P. Leder,et al.  The int‐2 gene product acts as an epithelial growth factor in transgenic mice. , 1990, The EMBO journal.

[47]  R. Callahan,et al.  Mutations in human breast cancer: an overview. , 1989, Journal of the National Cancer Institute.

[48]  D. Page.  Pathology of preinvasive and early breast cancer. , 1989, Current opinion in oncology.

[49]  P. Jolicoeur,et al.  Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene , 1989, Cell.

[50]  H. Varmus,et al.  Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice , 1988, Cell.

[51]  R. Cardiff,et al.  Proto-neoplasia revisited: the molecular biology of mouse mammary hyperplasia. , 1988, Anticancer research.

[52]  P. Leder,et al.  Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.

[53]  W D Dupont,et al.  Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.

[54]  R. Cardiff,et al.  Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus. , 1984, Journal of the National Cancer Institute.

[55]  F. Basolo,et al.  Lobuloalveolar differentiation and tumorigenesis: two separate activities of mouse mammary tumor virus. , 1983, Cancer research.

[56]  J. Cohen,et al.  Development of a mouse mammary tumor virus-negative mouse strain: a new system for the study of mammary carcinogenesis , 1982, Journal of virology.

[57]  R. Pingitore,et al.  Relationships between Morphology and Viral Etiology in Mammary Tumors of BALB/cfC3H and BALB/cfRIII Mice 1 , 1982, Tumori.

[58]  F. Squartini,et al.  Development, morphology, and progression of mammary tumors during and after fertile life in BALB/cfRIII mice. , 1981, Journal of the National Cancer Institute.

[59]  H. Varmus,et al.  Endogenous mammary tumour virus DNA varies among wild mice and segregates during inbreeding , 1979, Nature.

[60]  R. Cardiff,et al.  Biology of breast preneoplasia , 1977, Cancer.

[61]  S. Wellings,et al.  Preneoplastic lesions of the human mammary gland transplanted into the nude athymic mouse. , 1976, Cancer research.

[62]  J. Rice,et al.  Preneoplastic lesions in the human breast. , 1976, Science.

[63]  H M Jensen,et al.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. , 1975, Journal of the National Cancer Institute.

[64]  J. T. Young,et al.  The in vivo life span of normal and preneoplastic mouse mammary glands: a serial transplantation study. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[65]  L. Foulds.  The Histologic Analysis of Mammary Tumors of Mice. II. The Histology of Responsiveness and Progression. The Origins of Tumors , 1956 .

[66]  Larissa B. Thackray,et al.  Programmed cell death and mammary neoplasia. , 1996, Cancer treatment and research.

[67]  R. Cardiff,et al.  Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. , 1994, Genes & development.

[68]  R. Cardiff,et al.  Transgenic mouse models of mammary tumorigenesis. , 1993, Cancer surveys.

[69]  R. Cardiff,et al.  Mammary Morphogenesis and Oncogenes , 1992 .

[70]  R. Callahan.  Oncogenes and breast cancer progression. , 1991, Basic life sciences.

[71]  I. Keydar,et al.  Breast cancer : progress in biology, clinical management, and prevention : proceedings of the International Association for Breast Cancer Reseach Conference, Tel-Aviv, Israel, March 1989 , 1989 .

[72]  R. Cardiff.  Cellular and molecular aspects of neoplastic progression in the mammary gland. , 1988, European journal of cancer & clinical oncology.

[73]  D. Gallahan,et al.  Mammary tumorigenesis in feral species of the genus Mus. , 1986, Current topics in microbiology and immunology.

[74]  R. Cardiff,et al.  MuMTV Genotype, Protoneoplasia, and Tumor Progression , 1986 .

[75]  R. Cardiff,et al.  Mammary tumors in feral mice lacking MuMTV DNA. , 1985, Journal of experimental pathology.

[76]  R. Cardiff.  Protoneoplasia: the molecular biology of murine mammary hyperplasia. , 1984, Advances in cancer research.

[77]  Freddy Homburger,et al.  The physiopathology of cancer , 1959 .